Maximum Daily Dose of Sertraline
The maximum daily dose of sertraline for adults is 200 mg per day, with no dose reduction required for elderly patients based on age alone, though patients with hepatic impairment should receive lower or less frequent dosing. 1
Standard Adult Dosing
- The recommended starting dose for adults is 25–50 mg once daily, which can be increased in 25–50 mg increments at weekly intervals if adequate response is not achieved within 2–4 weeks 1, 2
- The maximum dose is 200 mg per day for all adult patients, including those being treated for depression, anxiety, or chronic agitation in dementia 1, 3
- Sertraline may be administered at any time of day as a single daily dose, though morning administration is preferable if insomnia occurs as a side effect, while evening dosing may be better if sedation or nausea develop 4
Elderly Patients (≥60 Years)
- No dosage reduction is required for elderly patients based on age alone—the same 25–50 mg starting dose and 200 mg maximum apply 1, 5
- Elderly patients exhibit approximately 40% lower plasma clearance compared to younger adults, resulting in higher steady-state concentrations, but this does not necessitate routine dose adjustment 1
- Steady-state is achieved after 2–3 weeks in older patients (versus 1 week in younger adults) due to reduced clearance 1
- The starting dose of 25–50 mg/day with titration to a maximum of 200 mg/day remains appropriate for elderly patients with dementia-related agitation 3
Hepatic Impairment
- In patients with mild hepatic impairment (Child-Pugh scores 5–8), sertraline clearance is reduced by approximately 3-fold, resulting in significantly higher drug exposure 1
- A lower or less frequent dose should be used in patients with liver disease, though specific reduced dosing regimens are not defined in the FDA label 1
- The effects of sertraline in patients with moderate to severe hepatic impairment have not been studied, so use must be approached with extreme caution 1
Renal Impairment
- No dose adjustment is required for renal impairment, including patients on hemodialysis, as sertraline is extensively metabolized and renal excretion of unchanged drug is minimal 1
- Pharmacokinetics and protein binding remain unaltered in patients with mild to severe renal dysfunction (creatinine clearance 10–60 mL/min) 1
Clinical Considerations
- Sertraline exhibits wide interpatient variability in steady-state plasma concentrations (up to 15-fold) at standard doses of 50–150 mg/day, but therapeutic drug monitoring is not routinely recommended due to lack of established concentration-response relationships 6
- The elimination half-life ranges from 22–36 hours, supporting once-daily dosing 6, 7
- Extended trials or higher doses (up to 200 mg/day) may benefit elderly patients with persistent depression after initial treatment at 100 mg/day, with cumulative response rates improving from 37% to 52% in nursing home residents 8
Common Pitfalls to Avoid
- Do not exceed 200 mg per day in any patient population, as higher doses have not been studied and provide no additional benefit 1
- Do not assume elderly patients require lower doses based solely on age—use the same dosing range unless hepatic impairment is present 1, 5, 2
- Do not abruptly discontinue sertraline—gradual tapering is required to minimize withdrawal symptoms 1
- Do not overlook hepatic function—patients with liver disease require dose reduction, whereas those with renal impairment do not 1